Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists

Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists

US Patent 7915448 · Granted Mar 29, 2011

Estimated economic value: $633,220,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Photoactivated adenylyl cyclase2025
Solid pharmaceutical preparation2025
Heterocyclic derivatives as Nav1.7 and Nav1.8 blockers2024
Benzazepine derivatives2023
Amide derivatives as Nav1.7 and Nav1.8 blockers2021
Biaryloxy derivatives as TTX-S blockers2021
Benzazepine derivatives2021
Azaspiro derivatives as TRPM8 antagonists2018
Aryl substituted carboxamide derivatives as calcium or sodium channel blockers2016
Imidazopyridine compounds2016
Imidazopyridine compounds2016
4-[5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile crystalline po2015